Maura Gillison, Who Transformed the Treatment of Mouth and Throat Cancers, Dies at 61
The oncology community mourns the death of Maura Gillison, a doctor who transformed the treatment of mouth and throat cancers.
📍 The outcome
Maura Gillison died at age 61. She was recognized by ASCO and others for transforming the treatment of mouth and throat cancers.
Epilogue added 43d ago, after coverage quieted.
The obvious questions
How old was Maura Gillison at the time of her death?
She was 61.
What specific medical fields did Maura Gillison impact?
She transformed the treatment of mouth and throat cancers.
Which medical organization acknowledged her loss?
The American Society of Clinical Oncology (ASCO).
The story so far
Maura Gillison has died at the age of 61. She was recognized for her work in transforming the treatment of mouth and throat cancers.
Coverage from the Wall Street Journal and Magzter emphasizes her impact on cancer treatment, while Oncodaily reports that the American Society of Clinical Oncology (ASCO) joined the community in mourning her loss. Reports from The Times of India highlight the growing link between HPV and head and neck cancers, noting that the virus does not only cause cervical cancer.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 43d ago.
Who reported it (4)
- Doctor Transformed the Treatment Of Mouth and Throat Cancers Magzter · 47d ago
- Miguel Bronchud: ASCO Joins the Oncology Community in Mourning the Loss of Maura L. Gillison Oncodaily · 47d ago
- HPV doesn't just cause cervical cancer: Doctor explains its growing link to head and neck cancers The Times of India · 47d ago
- Maura Gillison, Who Transformed the Treatment of Mouth and Throat Cancers, Dies at 61 WSJ · 47d ago broke it first
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
People, places & organizations
Topics
Related trends
CRISPR makes prostate cancer vulnerable to immunotherapy
New CRISPR gene-editing research indicates a method to improve the immune system's ability to detect and target prostate cancer tumors.
Colorectal cancer is on the rise — and often overlooked
Medical experts and patient accounts highlight an increasing prevalence of early-onset colorectal cancer and the risks associated with missed symptoms.
Creatine supplements may help halt cancer growth, study suggests
Scientific research into the impact of creatine supplementation on cancer development is sparking conflicting reports regarding its potential risks and benefits.
Leading oncologist reveals 6 habits that could promote longevity and reduce your risk of chronic illness
A leading oncologist is challenging traditional wellness norms by promoting six habits for longevity, including the surprising inclusion of ice cream.
Only 13% survive this cancer. A blood test just detected 90% of early cases
A new blood gene test has demonstrated the ability to detect 90% of early-stage pancreatic cancers, a disease with a 13% survival rate.
Second prostate-specific membrane antigen PET scan can change treatment for nearly half of prostate cancer patients
A second PSMA PET scan may alter the treatment course for nearly 50% of prostate cancer patients, according to new study data.